A Longitudinal Investigation of the Relationships Between Patient-Reported Symptoms and Survival Among Patients With HR+/HER2- Metastatic Breast Cancer (MBC) Treated With Abemaciclib in the Phase 2 Monarch 1 Trial
Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.091
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2017
Authors
Publisher
Elsevier BV